586 studies found for:    "Diabetic Angiopathies"
Show Display Options
Rank Status Study
21 Recruiting Pexiganan Versus Placebo Control for the Treatment of Mild Infections of Diabetic Foot Ulcers
Condition: Diabetic Foot Infection
Interventions: Drug: Topical pexiganan cream 0.8%;   Drug: Topical placebo cream;   Other: Standard wound care
22 Terminated Evaluation of Single Nucleotide Polymorphisms (SNPs) in Patients With and Without Diabetic Macular Edema
Conditions: Diabetic Retinopathy;   Diabetic Macular Edema
23 Unknown  Clinical Evaluation of the SNaP Wound Care System
Conditions: Acute and Chronic Wounds;   Pressure Ulcers;   Trauma Wounds;   Diabetic Foot Ulcers;   Venous Stasis Ulcers
Intervention: Device: SNaP Wound Care System
24 Terminated Extension Study of Long-term Safety and Tolerability of Octreotide Acetate in Patients With Moderately Severe or Severe Non-proliferative Diabetic Retinopathy or Low Risk Proliferative Diabetic Retinopathy
Condition: Diabetic Retinopathy
Intervention: Drug: Octreotide acetate in microspheres
25 Completed
Has Results
Study Of The Effect Of Fragmin In The Treatment Of Neuroischaemic Foot Ulcers In Diabetic Patients
Condition: Diabetic Foot Ulcer
Interventions: Drug: Fragmin/ Dalteparin Sodium;   Drug: Placebo for Fragmin/ Dalteparin Sodium
26 Completed Investigation of Subatmospheric Pressure Dressing on Pressure Ulcer Healing
Condition: Diabetic Foot Ulcers
Intervention: Procedure: Prevention of Pressure Ulcers
27 Completed Phenotyping Diabetic Retinopathy
Condition: Diabetic Retinopathy
28 Completed
Has Results
Use of Ranibizumab to Treat Rubeosis in Diabetics Prior to Cataract Surgery
Conditions: Rubeosis Iridis;   Proliferative Diabetic Retinopathy
Intervention: Drug: Ranibizumab
29 Recruiting Proteomic Prediction and Renin Angiotensin Aldosterone System Inhibition Prevention Of Early Diabetic nephRopathy In TYpe 2 Diabetic Patients With Normoalbuminuria
Conditions: Diabetic Nephropathy;   Diabetic Retinopathy
Interventions: Drug: Spironolactone;   Drug: Placebo;   Drug: Standard care
30 Completed
Has Results
OASIS Wound Matrix (Oasis) Mechanism of Action
Conditions: Diabetic Foot Ulcers (DFU);   Venous Stasis Ulcers (VSU)
Intervention: Device: OASIS Wound Matrix
31 Recruiting The Sorbact® Antimicrobial Dressing in the Holistic Wound Management Of Diabetic Foot ulCers (Phase III Study)
Condition: Foot Ulcer, Diabetic
Interventions: Device: Sorbact®;   Device: Best local cares
32 Completed Unilateral Bevacizumab for Bilateral Diabetic Macular Edema
Conditions: Diabetic Macular Edema;   Diabetic Retinopathy
Intervention: Drug: bevacizumab
33 Unknown  Bevacizumab as Adjunctive Treatment to Laser Panretinal Photocoagulation for Proliferative Diabetic Retinopathy
Condition: Proliferative Diabetic Retinopathy
Interventions: Procedure: Panretinal photocoagulation;   Procedure: Procedure: Panretinal Photocoagulation (PRP) Drug: Intravitreous injection of Bevacizumab
34 Completed Intravitreal Bevacizumab Pretreatment for Reducing Preretinal Hemorrhage in Diabetic Vitrectomy
Condition: Proliferative Diabetic Retinopathy
35 Recruiting CSTC1 for Diabetic Foot Ulcers Phase II Study
Conditions: Diabetic Foot Ulcer;   Diabetes Mellitus;   Wounds
Interventions: Drug: CSTC1;   Drug: CSTC1 Matched vehicle
36 Not yet recruiting A Randomized Comparison of AmnioClear™ Human Allograft Amniotic Membrane vs. Moist Wound Dressing in the Treatment of Diabetic Wounds
Conditions: Diabetic Foot Ulcers;   Wound Care
Intervention: Biological: AmnioClear™ Human Allograft Amniotic Membrane
37 Recruiting WEMR With Clinical Decision Support for Diabetic Foot Ulcers
Condition: Diabetic Foot Ulcers
38 Recruiting Outpatient Nurse Managed Counseling Program for Patients With Diabetic Foot Ulceration
Condition: Diabetic Foot Ulcer
Intervention: Behavioral: Nursing counseling
39 Active, not recruiting Confronting Unequal Eye Care in Pennsylvania
Conditions: Diabetic Retinopathy;   Diabetes Mellitus, Type 2
Interventions: Behavioral: Behavioral Activation;   Behavioral: Supportive Therapy
40 Not yet recruiting Feasibility Study of DermGEN for Diabetic Foot Ulcer Treatment
Conditions: Diabetes Type I;   Diabetes Type II
Intervention: Biological: DermGEN

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years